Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
51
days
Clinical and economic impact on people with relapsing-remitting multiple sclerosis in the United States: a matched-cohort study
AuthorsNupur Greene; Ashis K. Das; Ines Hemim; Eunice Chang; Marian H. Tarbox; Keiko Higuchi
Affiliations1. Sanofi; 2. ADVI Health
89
days
Prognostic value of HALP score in non-small cell lung cancer (NSCLC) patients with first-line chemotherapy combined with immunotherapy: a real-world retrospective study
AuthorsYaping Zhang; Keda Shao; Xiaodong Cao; Guifang Gu; Wenxian Wang
Affiliations1. Department of Respiratory Medicine, Shangyu People’s Hospital of Shaoxing; 2. Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences
124
days
Comparison of incontinence quality of life scores in patients with type 2 diabetes mellitus treated and not treated with sodium-glucose cotransporter 2 inhibitors
AuthorsAhmet Gorgel; Murat Akay; Suleyman Baldane
Affiliations1. Department of Endocrinology and Metabolism, Selcuk University Faculty of Medicine
180
days
Refractory arterial hypertension: important, but suboptimally characterized
AuthorsGoran Koraćević; Milovan Stojanović; Marija Zdravković; Suzana Otašević; Miloš Zdravković; Miomir Randjelović; Gordana Lazarević; Dimitrije Pavlović
Affiliations1. Department for Cardiology, University Clinical Center Niš; 2. Faculty of Medicine, University of Niš; 3. Institute for Treatment and Rehabilitation Niška Banja; 4. Faculty of Medicine, Belgrade University; 5. University Hospital Medical Center Bežanijska Kosa; 6. Public Health Institute Niš; 7. Department for Cardiac Surgery, University Clinical Center Nis; 8. Department of Plastic and Reconstructive Surgery, University Clinical Center Niš
53
days
Real-world comparative safety and effectiveness of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation: a prospective cohort study
AuthorsNawal Alsubaie; Zafar Ali Shah; Muhammad Ilyas; Amani S. Alrossies; Ammena Y. Binsaleh; Syed Muzammil Shah
Affiliations1. Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University; 2. Department of Agricultural Chemistry & Biochemistry, Faculty of Nutrition Sciences, The University of Agriculture; 3. Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota; 4. Department of Cardiology, Lady Reading Hospital Peshawar
98
days
Pharmacologic strategies in prediabetic neuropathy
AuthorsJenyfer María Fuentes-Mendoza; Marcio José Concepción-Zavaleta; Julian A. García-Ramírez; Natalia A. Suyón-Ríos; Luis Concepción-Urteaga; Arturo Basurto-Ayala; José Paz-Ibarra
Affiliations1. Grupo de Investigación en Neurociencias, Metabolismo, Efectividad Clínica y Salud Pública, Universidad Científica del Sur; 2. School of Medicine, Universidad Nacional de Trujillo; 3. Carrera de Medicina Humana, Facultad de Ciencias de la Salud, Universidad San Ignacio de Loyola; 4. School of Medicine, Universidad Nacional Mayor de San Marcos; 5. Endocrinology Department, Hospital Nacional Edgardo Rebagliati Martins
112
days
Cost-effectiveness of nasal adrenaline in the treatment of anaphylaxis
AuthorsShuaib Nasser; Luca Bottazzi; Andrea Lang; Rebecca Skou; Anne Danø; Peter Carlqvist
Affiliations1. Cambridge University Hospital NHS Foundation Trust; 2. Nordic Market Access NMA AB; 3. ALK; 4. Inspiria
79
days
Cross-publisher agreement on the defining principles of plain language summaries of publications (PLSPs)
AuthorsSophie Nobes; Kelly Soldavin; Rachel Jenkins; Hamish McDougall; Joanne Walker; Laura Dormer; Vicky Sanders
Affiliations1. Oxford PharmaGenesis; 2. Taylor & Francis Group; 3. Sage; 4. Becaris Publishing
93
days
Initiating dextromethorphan-bupropion extended release in patients with major depressive disorder: Delphi panel expert consensus recommendations
AuthorsAnita H. Clayton; Gus Alva; Phillip Bowman; Erin Crown; Bibi Das; Paul Doghramji; Brooke Kempf; Andrew Muzyk; Jeremy Schreiber; John J. Miller
Affiliations1. Department of Psychiatry and Neurobehavioral Sciences, University of Virginia School of Medicine; 2. U.C. Riverside Medical School; 3. Bowman Medical Group; 4. Pennsylvania Mental Health Initiative; 5. Private Practice, Palo Alto; 6. Pottstown Medical Specialists; 7. Indiana University Indianapolis; 8. Campbell University College of Pharmacy and Health Sciences; 9. West Liberty University; 10. Brain Health
68
days
Exploring preferences of patients, care partners, and prescribers for an injectable antipsychotic administered once every 2 months for treatment of schizophrenia: a plain language summary
AuthorsMurat Yildirim; Kristine Harrsen; Soma Nag; Xavier Guillaume; Roger S McIntyre; Sofia Pappa
Affiliations1. H. Lundbeck A/S; 2. Otsuka Pharmaceutical Development & Commercialization, Inc.; 3. Oracle Life Sciences; 4. Department of Psychiatry, University of Toronto; 5. Division of Psychiatry, Imperial College London; 6. West London NHS Trust
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days